Assessing the impact of sweeteners on gut microbiota & telomere length in Diabetic adults
Phase 2
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2023/07/055506
- Lead Sponsor
- MATCHA ANGELI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Eligible participants (age >18 years) with type 2 diabetes
The participants who accept to adhere to the dietary plan and avoid consuming other sources
of artificial sweeteners will be considered
Exclusion Criteria
Patients with Type 1 Diabetes
Patients with Gestational Diabetes Mellitus
Patients with an History of non-tolerance to artificial sweeteners
Patients who consumed any artificial sweeteners prior to the study in the last 1
month
Patients with malignancy, or had undergone chemo radio therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Artificial sweeteners, may alter the Gut Microbiota.Timepoint: 0 to 8 months
- Secondary Outcome Measures
Name Time Method Artificial sweeteners may modulate the length of telomereTimepoint: 0 to 8 months